Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11

Clinical trial condition

Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11

Explore clinical trials studying Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 trial results

Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00801489

Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details